National Charity Partners


We’re the only ones fighting over 200 cancers, including the 1 that matters most to you. Our life-saving work is funded entirely by the generosity of our supporters, so every step we make towards beating cancer relies on every pound, and every runner.

Thanks to our amazing supporters, survival rates across all forms of cancer have doubled in the last 40 years, but we can’t stop there. Our ambition is to accelerate progress and see three quarters of patients surviving cancer within the next 20 years.



There’s around 3 million people living with cancer in the UK today, and more than 360,000 are diagnosed every year.

At Macmillan, we give people with cancer everything we’ve got. If you’re diagnosed, your worries are our worries. We will move mountains to help you live life as fully as you can. And we don’t stop there. We’re going all out to find ever better ways to help people with cancer, helping to bring forward the day when everyone gets life-transforming support from day one.

Race for a reason and help us support everyone affected by cancer. Together, we can make a difference.



We are the UK’s leading kidney patient support charity, providing practical, financial, and emotional support for kidney patients and their families and campaigning to improve care services across the UK.

Everything we do is about ensuring that the patient voice is heard. From making a difference to health services and patient care to working in partnership to fund patient-centred research, we believe no one should face kidney disease alone.



Addenbrooke’s Charitable Trust (ACT) is the charity for Addenbrooke’s and the Rosie hospitals dedicated to making patient care even better.

Thanks to our amazing supporters, Addenbrooke’s and the Rosie hospitals can provide a level of patient care beyond that which can be delivered by NHS funding alone. Charitable donations fund high-tech equipment, specialist staff, extra comforts and vital research to find potential cures and help save lives locally, nationally and worldwide.